Navigation Links
Senesco Technologies, Inc. Announces Management Change
Date:11/16/2009

NEW BRUNSWICK, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT) today announced that, on November 16, 2009, Bruce C. Galton resigned from his position as a member of the board of directors. In addition, Mr. Galton resigned from his positions as the Company's President and Chief Executive Officer to pursue other interests. Mr. Galton and the Company currently are discussing the terms of Mr. Galton's separation with the Company.

On November 16, 2009, the Board of Directors appointed Jack Van Hulst, a current member of the Board of Directors, to serve as the Company's President and Chief Executive Officer.

Bruce Galton commented, "My goal has been to bring Senesco's Factor 5A technology to the clinic to determine its utility to treat multiple myeloma, a serious bone marrow cancer. The Company is poised to initiate its pivotal toxicology study to support an IND application. It has been an honor and a pleasure to bring the Company to this point."

Harlan Waksal, M.D., Senesco's Chairman, commented, "We wish Bruce well with his future endeavors, and we look forward to having Jack as our new President and Chief Executive Officer. I will continue to play an active role with the Company. The Board, management and all employees remain excited about the future of the Company."

Additional details regarding the foregoing are disclosed on the Company's Form 8-K filed today.

About Senesco Technologies, Inc.

Senesco Technologies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development o
'/>"/>

SOURCE Senesco Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Senesco Technologies to Present at 11th Annual Rodman & Renshaw Healthcare Conference
2. Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
3. Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing
4. ArborGen and Senesco Announce Wood Quality Results
5. Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors
6. Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
7. Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
8. Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
9. Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring
10. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
11. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Marktech Optoelectronics has introduced the MTE280xxx ... in the 280 nm wavelength range. This series joins ... from 280nm to 405nm. These new devices are suitable ... as curing. Mark Campito, Marktech’s CEO states that “what ... manufacturers is that we offer it in one of ...
(Date:9/22/2014)... who were treated with a statin in the hospital ... likely to survive than those who were not, according ... . This study was conducted by the same researchers ... can improve survival in victims of ischemic stroke., Ischemic ... a blood vessel that blocks blood from reaching areas ...
(Date:9/22/2014)... job it is to stop bleeding, are very simple. ... "feel" the physical environment around them, researchers at Emory ... surfaces with greater stiffness by increasing their stickiness, the ... other components of the clotting system, the researchers found. ... for, in that they are able to sense the ...
(Date:9/22/2014)... D.C. (PRWEB) September 22, 2014 ... Georgetown President John DeGioia on Friday renewed their ... for an additional five years to expand the ... biosecurity, nonproliferation and global climate, energy and environmental ... of an MOU originally signed in December 2009 ...
Breaking Biology Technology:Marktech Introduces its New Line of Deep UV Emitters 2Statin use during hospitalization for hemorrhagic stroke associated with improved survival 2Platelets modulate clotting behavior by 'feeling' their surroundings 2Lawrence Livermore Renews Pact with Georgetown University to Expand Research and Education in Science and Policy 2
... and PHILADELPHIA, July 4 ,Shire Limited (LSE:SHP, NASDAQ: SHPGY), ... earnings on,Thursday 31 July 2008, Results press ... BST / 07:00 EDT Investor meeting and conference ... Investor & Analyst meeting and conference call:, Angus ...
... Research Group has,released results from aboratory testing ... at Oregon State University which,demonstrated the Eniva ... for human cells. This third party testing ... effort to further identify,mechanisms by which the ...
... Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) today announced that ... its cash burn rate. As previously,announced, the Company ... acquisitions and mergers. In conjunction with this,process, the ... its VP,series of drugs, and has determined that ...
Cached Biology Technology:Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008 2Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2Vasogen Provides Corporate Update 2
(Date:9/23/2014)... DNA fragments called "jumping genes" that insert themselves into ... that phenomenon can result in age-related diseases such as ... report that the "jumping genes" in mice become active ... keeping them in check in order to take on ... in Nature Communications , Professor of Biology Vera ...
(Date:9/22/2014)... that after a long stay in the Intensive Care ... remain behind in patients, intestines. The team tested these ... when provoked by conditions that mimic the body,s stress ... mBio , the online open-access journal of the American ... treatment of ICU patients who can develop a life-threatening ...
(Date:9/22/2014)... September 23, 2014 A new American Cancer ... Nutrition Assistance Program (SNAP), previously known as the ... compared with income eligible non-participants. The authors say ... aimed at enhancing the dietary quality of SNAP ... low-income individuals and households with the resources to ...
Breaking Biology News(10 mins):A multi-function protein is key to stopping genomic parasites from 'jumping' 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 3Federal food program puts food on the table, but dietary quality could be improved 2
... Hidenori Ichijo and Hideki Nishitoh (The University of Tokyo) ... genetics of ALS. Amyotrophic lateral sclerosis (ALS), also ... fatal neurological disease involving the degeneration and death of ... the most common neuromuscular diseases worldwide, affecting as roughly ...
... sturgeons, more caviar will be exported from Caspian Sea ... of unacceptably permissive new trade quotas announced Thursday by ... Most sturgeon species are endangered and some, like beluga ... damage this ancient fish,s chance of recovery and survival, ...
... New research* shows that while engineered nanomaterials can ... food chain from single celled organisms to higher ... and there was no evidence of the nanomaterials ... results observed by researchers from the National Institute ...
Cached Biology News:New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 2New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 3New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 4Research measures movement of nanomaterials in simple model food chain 2
Request Info...
These macrocarriers are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 macrocarriers....
... 211 ] affinity isolated antibody aqueous solution ... (without Mg 2+ and Ca 2+ ), ... protease free) and 0.05% sodium azide. a synthetic ... Hck that contains tyrosine 207 and serine 209 ...
High voltage electrophoresis power supply...
Biology Products: